Catherine C. Turkel

2018

In 2018, Catherine C. Turkel earned a total compensation of $625.5K as President at Tokai Pharmaceuticals, a 9% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$118,965
Option Awards$81,272
Salary$357,673
Stock Awards$64,661
Other$2,930
Total$625,501

Turkel received $357.7K in salary, accounting for 57% of the total pay in 2018.

Turkel also received $119K in non-equity incentive plan, $81.3K in option awards, $64.7K in stock awards and $2.9K in other compensation.

Rankings

In 2018, Catherine C. Turkel's compensation ranked 11,131st out of 14,244 executives tracked by ExecPay. In other words, Turkel earned more than 21.9% of executives.

ClassificationRankingPercentile
All
11,131
out of 14,244
22nd
Division
Manufacturing
4,496
out of 5,765
22nd
Major group
Chemicals And Allied Products
1,704
out of 2,128
20th
Industry group
Drugs
1,444
out of 1,817
21st
Industry
Pharmaceutical Preparations
1,107
out of 1,391
20th
Source: SEC filing on May 15, 2019.

Turkel's colleagues

We found two more compensation records of executives who worked with Catherine C. Turkel at Tokai Pharmaceuticals in 2018.

2018

Gregory Flesher

Tokai Pharmaceuticals

Chief Executive Officer

2018

Jon Kuwahara

Tokai Pharmaceuticals

Senior Vice President of Finance and Administration

News

You may also like